Related Experiment Video

Updated: Aug 11, 2026

Dried Blood Spots - Preparing and Processing for Use in Immunoassays and in Molecular Techniques
11:28

Dried Blood Spots - Preparing and Processing for Use in Immunoassays and in Molecular Techniques

Published on: March 13, 2015

[Prevalence of viral hepatitis type C in blood donors in Peru]

Gustavo Farfán1, César Cabezas

  • 1Universidad Peruana Cayetano Heredia.

Revista De Gastroenterologia Del Peru : Organo Oficial De La Sociedad De Gastroenterologia Del Peru
|October 9, 2003
PubMed

Insights

Hepatitis C Virus (HVC) prevalence in Peruvian blood donors is low, with nationwide averages of 0.25% in 2000 and 0.60% in 2001. Further studies are recommended to assess HVC prevalence in the general population.

Area of Science:

  • Hepatology
  • Infectious Diseases
  • Public Health

Context:

  • Limited data exists on Hepatitis C Virus (HVC) prevalence in Peru's general population.
  • Blood donors represent a key demographic for epidemiological surveillance.

Purpose:

  • To determine the prevalence and geographical distribution of HVC among blood donors in Peru.
  • To establish baseline data for HVC infection rates nationwide.

Summary:

  • Data from Ministry of Health blood banks (2000-2001) revealed low HVC prevalence: 0.25% in 2000 and 0.60% in 2001.
  • Prevalence varied by region, with higher rates observed in the jungle and coast compared to the Sierra.
  • Hepatitis B markers (HbsAg, Anti-HBc) showed higher prevalence rates.

Impact:

  • Findings indicate a low HVC burden among blood donors in Peru.
  • Highlights the need for broader epidemiological studies in the general population to confirm these trends.
  • Provides essential data for public health strategies and blood transfusion safety.
Abstract

More Related Videos

Real-Time Polymerase Chain Reaction-Based Detection and Quantification of Hepatitis B Virus DNA04:11

Real-Time Polymerase Chain Reaction-Based Detection and Quantification of Hepatitis B Virus DNA

Published on: December 15, 2023

COVID-19 Seroprevalence Test for IgG Antibody Levels Among Healthy Donors Across Different Pandemic Phases in Jeddah04:43

COVID-19 Seroprevalence Test for IgG Antibody Levels Among Healthy Donors Across Different Pandemic Phases in Jeddah

Published on: June 24, 2025

Related Concept Videos

Cytomegalovirus Disease01:27

Cytomegalovirus Disease

Cytomegalovirus (CMV) disease is caused by human cytomegalovirus, a double-stranded DNA virus of the Herpesviridae family. While primary CMV infection is often asymptomatic in immunocompetent individuals, the virus can cause severe disease in neonates and immunocompromised patients. CMV is the most common cause of congenital viral infection in the United States, and a major pathogen in solid organ and hematopoietic stem cell transplant recipients.CMV is transmitted via bodily fluids, sexual...
Hepatitis01:25

Hepatitis

Hepatitis is an inflammatory condition of the liver most commonly caused by hepatotropic viruses (A–E), though non-infectious causes such as alcohol and drugs also exist.Hepatitis AHepatitis A virus (HAV) is a non-enveloped RNA virus of the Picornaviridae family. It is primarily transmitted via the fecal-oral route, typically through ingestion of contaminated food or water. After ingestion, HAV enters the bloodstream through the oropharynx or intestinal epithelium and reaches the liver. The...
Viral Hepatitis I: Introduction01:28

Viral Hepatitis I: Introduction

Viral hepatitis is an inflammatory condition of the liver caused by infection with hepatotropic viruses, most commonly hepatitis A, B, C, D, and E. Despite variations in structure and transmission, all viruses mentioned infect hepatocytes and provoke immune responses that can hinder liver function. Additionally, some non-hepatotropic viruses can also lead to hepatic inflammation.Hepatitis A VirusHepatitis A virus (HAV) is transmitted through the fecal–oral route, typically by ingestion of food...